Literature DB >> 2004476

Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom.

J V Parle1, J A Franklyn, K W Cross, S C Jones, M C Sheppard.   

Abstract

Increasing use of assays for TSH with improved sensitivity as a first-line test of thyroid function has raised questions regarding prevalence and clinical significance of abnormal results, especially values below normal. We have assessed the thyroid status of 1210 patients aged over 60 registered with a single general practice by measurement of serum TSH using a sensitive assay. High TSH values were more common in females (11.6%) than males (2.9%). TSH values below normal were present in 6.3% of females and 5.5% of males, with values below the limit of detection of the assay present in 1.5% of females and 1.4% of males. Anti-thyroid antibodies were found in 60% of those with high TSH but only 5.6% of those with subnormal TSH. Eighteen patients were hypothyroid (high TSH, low free thyroxine) and one thyrotoxic (low TSH, raised free thyroxine) at initial testing. Seventy-three patients with elevated TSH but normal free T4 were followed for 12 months; 13 (17.8%) developed low free T4 levels and commenced thyroxine, TSH returned to normal in four (5.5%) and 56 (76.7%) continued to have high TSH values. Sixty-six patients with TSH results below normal were followed. Of the 50 subjects with low but detectable TSH at initial testing, 38 (76%) returned to normal at 12 months; of those 16 with undetectable TSH followed, 14 (87.5%) remained low at 12 months. Only one subject (who had an undetectable TSH) developed thyrotoxicosis. In view of the marked prevalence of thyroid dysfunction in the elderly, we suggest that screening of all patients over 60 should be considered.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004476     DOI: 10.1111/j.1365-2265.1991.tb01739.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  85 in total

1.  Lesson of the week: Deterioration of symptoms after start of thyroid hormone replacement.

Authors:  J S Murray; R Jayarajasingh; P Perros
Journal:  BMJ       Date:  2001-08-11

Review 2.  Management of the unexpected result: compensated hypothyroidism.

Authors:  R Benediktsson; A D Toft
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

3.  Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study.

Authors:  Andrea Radácsi; Gábor Kovács; Wolfdieter Bernard; Joachim Feldkamp; Franz A Horster; István Szabolcs
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

4.  Thyrotropin blood levels, subclinical hypothyroidism, and the elderly patient.

Authors:  Joanna Klubo-Gwiezdzinska; Leonard Wartofsky
Journal:  Arch Intern Med       Date:  2009-11-23

5.  Hypothyroidism, thyroxine treatment, and the heart.

Authors:  M Gammage; J Franklyn
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

6.  Does an increase in the sensitivity of serum thyrotropin assays reduce diagnostic costs for thyroid disease in the community?

Authors:  M P Vanderpump; R H Neary; K Manning; R N Clayton
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

7.  [Incidence and characteristics of clinical and sub-clinic hyperthyroidism].

Authors:  M N Soler Solé; P Godoy; M Amorós Brotons; S Sarriegui Domínguez; F Rius Riu
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 8.  Subclinical hyperthyroidism: to treat or not to treat?

Authors:  E H Hoogendoorn; M den Heijer; A P J van Dijk; A R Hermus
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

9.  Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women.

Authors:  Vicky A LeGrys; Michele Jonsson Funk; Carol E Lorenz; Ayush Giri; Rebecca D Jackson; JoAnn E Manson; Robin Schectman; Todd L Edwards; Gerardo Heiss; Katherine E Hartmann
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

10.  Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.

Authors:  J V Parle; J A Franklyn; K W Cross; S R Jones; M C Sheppard
Journal:  Br J Gen Pract       Date:  1993-03       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.